October 30, 2013
Dainippon Sumitomo Pharma (DSP) said on October 28 that its local licensee has submitted an application for regulatory approval of its atypical antipsychotic agent lurasidone HCl in Taiwan, the first application for the drug filed in Asia. The application was...read more